Search
for

    Sort by

    Research 61–90 of 1000+

    1. TREATMENT OF HAIR LOSS วารสารเภสัชวิทยา (Thai Journal of Pharmacology) · 2000
    2. Relative efficacy of microneedling in the treatment of pattern hair loss: a protocol for a systematic review with network meta-analysis 2022
    3. 370 An analysis of androgenetic alopecia treatment content on Instagram and TikTok Journal of Investigative Dermatology · 2022
    4. Novel drugs of United States Food and Drug Administration approved in 2024 Korean Journal of Clinical Pharmacy · 2026
    5. Inconsistent platelet-rich plasma product from devices cleared by the US FDA: A retrospective review of clinic data Journal of the American Academy of Dermatology · 2021 · 6 citations
    6. Androgenetic Alopecia: An Update of Treatment Options Drugs · 2016 · 110 citations
    7. The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata Hair transplant forum international · 2022
    8. Medical Treatment of Hair Loss 2010 · 4 citations
    9. What's New: Newly Approved Drugs for Children Pediatrics in review · 2003
    10. Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety Cureus · 2026
    11. A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System Military medicine · 2024
    12. FDA declines approval of testosterone drug for third time ˜The œLancet. Diabetes & endocrinology · 2013 · 2 citations
    13. FDA declines approval of testosterone drug for third time 2013
    14. A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system Scientific Reports · 2025 · 2 citations
    15. Not Its Crowning Glory: Obstacles for FDA in Regulating Ingested Dietary Supplements Purporting to Prevent Hair Loss Digital Access to Scholarship at Harvard (DASH) (Harvard University) · 2005
    16. Lilly arthritis drug approved for alopecia C&EN global enterprise · 2022
    17. Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS) The Aging Male · 2026
    18. NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders Journal of Medicinal Chemistry · 2025 · 45 citations
    19. ‘Ritlecitinib: unveiling hair regrowth for alopecia areata’ Annals of Medicine and Surgery · 2024
    20. DRUG NEWS ​​​​​​​​​​​​​​Nursing2023 · 2013
    21. Exploring novel management options for alopecia areata The American Journal of Managed Care · 2026
    22. PHARMACOTHERAPY ALOPECIA ANDROGENETIC IN MEN DOAJ (DOAJ: Directory of Open Access Journals) · 2013
    23. Medical treatment of the hairline and temple points International Society of Hair Restoration Surgery · 2008
    24. 5종의 한약 추출물이 함유된 헤어 에센스제품(HHRHG0202-80)이 in vitro 및 in vivo에서 육모 및 탈모 방지에 미치는 효과 大韓韓醫學會誌 = Journal of Korean Oriental Medicine · 2004
    25. Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases Oncotarget · 2016 · 24 citations
    26. The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms JEADV Clinical Practice · 2022 · 1 citations
    27. High-throughput screening of small molecule Wnt/β-catenin activators for hair and nail growth Communications Biology · 2026
    28. An update on nanocarriers for follicular-targeted drug delivery for androgenetic alopecia topical treatment Expert Opinion on Drug Delivery · 2025
    29. Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists Dermatology and Therapy · 2025
    30. Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib JAAD Case Reports · 2024